PCN64 Evaluating the Cost-Effectiveness of the Addition of Rituximab to Chemotherapy in the First Line Treatment of Follicular Lymphoma Patients in the UK

Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1165
https://www.valueinhealthjournal.com/article/S1098-3015(11)02727-6/fulltext
Title : PCN64 Evaluating the Cost-Effectiveness of the Addition of Rituximab to Chemotherapy in the First Line Treatment of Follicular Lymphoma Patients in the UK
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02727-6&doi=10.1016/j.jval.2011.08.1165
First page : A445
Section Title : Cancer
Open access? : No
Section Order : 1122
Categories :
Tags :
Regions :
ViH Article Tags :